Heron Therapeutics (LTS:0J4V) Purchase Of Investment : $-111.6 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Heron Therapeutics Purchase Of Investment?

Heron Therapeutics's purchase of investment for the three months ended in Mar. 2024 was $-37.9 Mil. It means Heron Therapeutics spent $37.9 Mil on purchasing investments. Heron Therapeutics's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was $-111.6 Mil.

Compared with last quarter ($-23.3 Mil in Dec. 2023 ), Heron Therapeutics spent more money on purchasing investments in Mar. 2024 ($-37.9 Mil).

Heron Therapeutics Purchase Of Investment Historical Data

The historical data trend for Heron Therapeutics's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heron Therapeutics Purchase Of Investment Chart

Heron Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Investment

Get a 7-Day Free Trial

-477.04

-134.01

-129.22

-145.68

-87.66

Heron Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Purchase Of Investment	Get a 7-Day Free Trial															-13.94	-14.44	-35.93	-23.35	-37.89

Heron Therapeutics Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-111.6 Mil.

Heron Therapeutics Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Heron Therapeutics's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Heron Therapeutics (LTS:0J4V) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heron Therapeutics Inc (LTS:0J4V) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

HRTX:USA AXD2:Germany AXD2:Germany

Address

4242 Campus Point Court, Suite 200, San Diego, CA, USA, 92121

Website

https://www.herontx.com

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

Heron Therapeutics (LTS:0J4V) Headlines

No Headlines